<DOC>
	<DOCNO>NCT00886704</DOCNO>
	<brief_summary>An increase intake omega-3 fatty acid increase Omega-3 Index . Current evidence indicates may lead reduction risk sudden cardiac death atherosclerotic disease like myocardial infarction . The aim study investigate , supplement convenience drink omega-3 fatty acid influence Omega-3 Index , compare unsupplemented match convenience drink . Palatability safety drink also assess .</brief_summary>
	<brief_title>Omega-3 Fatty Acids , Omega-3 Index , Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>1 . Subjects must meet current guideline criterion atherosclerosis , like coronary , peripheral carotid artery disease , like previous myocardial infarction acute coronary syndrome , coronary revascularization ( operation transluminally ) , positive angiography ultrasound . 2 . Age : 30 75 year 3 . Low Omega3 Index ( &lt; 5 % ) 4 . Subjects must adequate fluency German English complete baseline followup interview . 5 . Stable intake food contain EPA+DHA study 6 . Subjects must able willing give write informed consent , comply study procedure . 1 . Subjects intake omega3 fatty acid mandatory accord recent treatment guideline take omega3 fatty acid supplement regular basis . 2 . Patients consume &gt; 2 portion fatty fish / week 3 . Patients serious bleed disorder . Use platelet inhibitor anticoagulation target INR 2.0 3.0 exclusion criterion . 4 . Subjects acute lifethreatening condition , collapse shock , acute myocardial infarction ( last three month ) , stroke , embolism . 5 . Subjects significant medical comorbidity , seriously limit life expectancy insulintreated diabetes mellitis BMI &gt; 30 6 . Allergy/intolerance history hypersensitivity component study intervention , like lactose . 7 . Pregnant subject due possible teratogenic effect study nutrition fetus breastfeed subject . In addition , woman childbearing potential practice medically accept method contraception exclude . 8 . Subjects , investigator 's judgement , likely able comply study protocol know drug alcohol abuse/dependence past 2 year . 9 . Use investigational agent within 30 day prior t0</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Omega-3 fatty acid</keyword>
	<keyword>dietary supplementation</keyword>
	<keyword>atherosclerosis</keyword>
</DOC>